Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Diamantopoulos PT, Symeonidis A, Pappa V, Kotsianidis I, Galanopoulos A, Pontikoglou C, Anagnostopoulos A, Vassilopoulos G, Zikos P, Hatzimichael E, Papaioannou M, Megalakaki A, Repousis P, Kotsopoulou M, Dimou M, Solomou E, Dryllis G, Tsokanas D, Papoutselis MK, Papageorgiou S, Kyrtshonis MC, Kourakli A, Papadaki H, Panayiotidis P, Viniou NA. Diamantopoulos PT, et al. Among authors: solomou e. Br J Haematol. 2021 Mar;192(6):978-987. doi: 10.1111/bjh.17062. Epub 2020 Aug 30. Br J Haematol. 2021. PMID: 32862447 Free article.
Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine.
Kontandreopoulou CN, Diamantopoulos PT, Giannopoulos A, Symeonidis A, Kotsianidis I, Pappa V, Galanopoulos A, Panayiotidis P, Dimou M, Solomou E, Loupis T, Zoi K, Giannakopoulou N, Dryllis G, Hatzidavid S, Viniou NA; Hellenic MDS study Group. Kontandreopoulou CN, et al. Among authors: solomou e. Leuk Lymphoma. 2022 Mar;63(3):729-737. doi: 10.1080/10428194.2021.1998484. Epub 2021 Nov 5. Leuk Lymphoma. 2022. PMID: 34738857
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome.
Diamantopoulos PT, Charakopoulos E, Symeonidis A, Kotsianidis I, Viniou NA, Pappa V, Pontikoglou C, Tsokanas D, Drakos G, Kourakli A, Solomou E, Hatzimichael E, Pouli A, Kotsopoulou M, Asmanis E, Dimou M, Panayiotidis P, Papageorgiou S, Vassilopoulos G, Anagnostopoulos A, Vassilakopoulos T, Papadaki H, Galanopoulos A. Diamantopoulos PT, et al. Among authors: solomou e. Sci Rep. 2022 Oct 26;12(1):17914. doi: 10.1038/s41598-022-21933-7. Sci Rep. 2022. PMID: 36289284 Free PMC article.
Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
Filippidou M, Avgerinou G, Tsipou H, Tourkantoni N, Katsibardi K, Vlachou A, Roka K, Solomou E, Kattamis A. Filippidou M, et al. Among authors: solomou e. Br J Haematol. 2020 Aug;190(3):e157-e159. doi: 10.1111/bjh.16766. Epub 2020 Jun 12. Br J Haematol. 2020. PMID: 32529633 Free article. Clinical Trial. No abstract available.
Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.
Verigou E, Lampropoulou P, Smyrni N, Kolliopoulou G, Sakellaropoulos G, Starakis I, Zikos P, Solomou E, Symeonidis A, Karakantza M. Verigou E, et al. Among authors: solomou e. Cardiovasc Hematol Disord Drug Targets. 2015;15(2):148-61. doi: 10.2174/1871529x15666150701105822. Cardiovasc Hematol Disord Drug Targets. 2015. PMID: 26126819
102 results